IDE034
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IDE034, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types [Phase 1]